These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23675296)

  • 1. Persistently active microbial molecules prolong innate immune tolerance in vivo.
    Lu M; Varley AW; Munford RS
    PLoS Pathog; 2013 May; 9(5):e1003339. PubMed ID: 23675296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection.
    Lu M; Varley AW; Ohta S; Hardwick J; Munford RS
    Cell Host Microbe; 2008 Sep; 4(3):293-302. PubMed ID: 18779055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overproduction of acyloxyacyl hydrolase by macrophages and dendritic cells prevents prolonged reactions to bacterial lipopolysaccharide in vivo.
    Ojogun N; Kuang TY; Shao B; Greaves DR; Munford RS; Varley AW
    J Infect Dis; 2009 Dec; 200(11):1685-93. PubMed ID: 19860560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyloxyacyl hydrolase promotes the resolution of lipopolysaccharide-induced acute lung injury.
    Zou B; Jiang W; Han H; Li J; Mao W; Tang Z; Yang Q; Qian G; Qian J; Zeng W; Gu J; Chu T; Zhu N; Zhang W; Yan D; He R; Chu Y; Lu M
    PLoS Pathog; 2017 Jun; 13(6):e1006436. PubMed ID: 28622363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens.
    He YW; Li H; Zhang J; Hsu CL; Lin E; Zhang N; Guo J; Forbush KA; Bevan MJ
    Nat Immunol; 2004 Jan; 5(1):88-97. PubMed ID: 14691481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria.
    Munford RS; Varley AW
    PLoS Pathog; 2006 Jun; 2(6):e67. PubMed ID: 16846256
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial responses to endotoxins and Gram-negative bacteria.
    Heumann D; Roger T
    Clin Chim Acta; 2002 Sep; 323(1-2):59-72. PubMed ID: 12135807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transport and inactivation kinetics of bacterial lipopolysaccharide influence its immunological potency in vivo.
    Lu M; Munford RS
    J Immunol; 2011 Sep; 187(6):3314-20. PubMed ID: 21849675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin inactivation leads to decreased responsiveness to LPS in macrophages and dendritic cells and protects against LPS-induced toxicity in vivo.
    Jennings C; Kusler B; Jones PP
    Innate Immun; 2009 Apr; 15(2):109-20. PubMed ID: 19318421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria.
    Giordano NP; Cian MB; Dalebroux ZD
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32253250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haptoglobin improves acute phase response and endotoxin tolerance in response to bacterial LPS.
    Raju SM; Kumar AP; Yadav AN; Rajkumar K; Mvs S; Burgula S
    Immunol Lett; 2019 Mar; 207():17-27. PubMed ID: 30625342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1beta induces in vivo tolerance to lipopolysaccharide in mice.
    Alves-Rosa F; Vulcano M; Beigier-Bompadre M; Fernández G; Palermo M; Isturiz MA
    Clin Exp Immunol; 2002 May; 128(2):221-8. PubMed ID: 12041508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds.
    Heumann D; Lauener R; Ryffel B
    J Endotoxin Res; 2003; 9(6):381-4. PubMed ID: 14733725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 2: Kill the bacteria...and also their messengers?
    Munford R; Lu M; Varley A
    Adv Immunol; 2009; 103():29-48. PubMed ID: 19755182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in innate immune responses upon stimulation with gram-positive and gram-negative bacteria.
    Tietze K; Dalpke A; Morath S; Mutters R; Heeg K; Nonnenmacher C
    J Periodontal Res; 2006 Oct; 41(5):447-54. PubMed ID: 16953821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage Immune Memory Controls Endometriosis in Mice and Humans.
    Jeljeli M; Riccio LGC; Chouzenoux S; Moresi F; Toullec L; Doridot L; Nicco C; Bourdon M; Marcellin L; Santulli P; Abrão MS; Chapron C; Batteux F
    Cell Rep; 2020 Nov; 33(5):108325. PubMed ID: 33147452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage genetic reprogramming during chronic peritonitis is augmented by LPS pretreatment.
    Kanaan Z; Gardner S; Carruba C; Mattingly J; Druen D; Cheadle WG
    J Surg Res; 2012 Jun; 175(2):289-97. PubMed ID: 21696761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways.
    Zamyatina A; Heine H
    Front Immunol; 2020; 11():585146. PubMed ID: 33329561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4.
    Mandell L; Moran AP; Cocchiarella A; Houghton J; Taylor N; Fox JG; Wang TC; Kurt-Jones EA
    Infect Immun; 2004 Nov; 72(11):6446-54. PubMed ID: 15501775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator activated receptor gamma is not necessary for the development of LPS-induced tolerance in macrophages.
    Zingarelli B; Fan H; Ashton S; Piraino G; Mangeshkar P; Cook JA
    Immunology; 2008 May; 124(1):51-7. PubMed ID: 18028370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.